Michela Luciano,  Science Writer—

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in Acute Myeloid Leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as Scientific Writer in 2022. Outside of work, Michela is a passionate photographer. She enjoys mountain hikes, running, and spending as much time as possible outdoors.

Articles by Michela Luciano

Canada gives conditional OK to early Alzheimer’s drug Leqembi

Health Canada has conditionally approved Leqembi (lecanemab) for certain adults with early Alzheimer’s disease, making it the first treatment approved in Canada that targets an underlying cause of early Alzheimer’s by removing toxic amyloid-beta proteins from the brain. The therapy, co-developed by Eisai and Biogen, was cleared for…